Intellia Therapeutics (NTLA) CAPEX/Revenue US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
CAPEX/Revenue, % | 15.8% | 6.18% | 38.6% | 112.0% | 38.6% | 22.4% | |||
Changes by years, y/y, % | -5pp | -10pp | +32pp | +73pp | -73pp | +13.0% |
Intellia Therapeutics. CAPEX/Revenue, %
Intellia Therapeutics. CAPEX/Revenue, changes, pp
Intellia Therapeutics (NTLA) CAPEX/Revenue US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
CAPEX/Revenue, % | 30.4% | 31.6% | 36.1% | 79.3% | 8.66% | 22.4% | ||
Changes by years, y/y, % | -381pp | +3pp | +4pp | +50pp | -22pp | |||
Changes by quarters, q/q, % | +2pp | +1pp | +4pp | +43pp | -71pp |